Restoration of cell-mediated immune responses with transfer factor.
Five anergic patients with chronic mucocutaneous candidiasis were given transfer factor from donors with positive delayed reactions to Candida. In each recipient, the delayed skin reactions of the transfer factor donors appeared in the recipients and no recipient developed reactivities not possessed by the donor. Prior to injection of transfer factor, in vitro stimulation of the patients' lymphocytes with antigens did not result in MIF production, however, after transfer factor this response was positive. Therapy with transfer factor alone did not have therapeutic benefit, however, in 2 patients treatment with amphotericin-B followed by transfer factor has produced cutaneous remissions of 18 months.
D002176:Candida albicans / Q000276:immunology; D002179:Candidiasis, Cutaneous / Q000628:therapy*; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007167:Immunotherapy; D008213:Lymphocyte Activation; D008263:Macrophage Migration-Inhibitory Factors / Q000096:biosynthesis; D009109:Mumps virus / Q000276:immunology; D012882:Skin Tests; D013299:Streptodornase and Streptokinase / Q000276:immunology; D014165:Transfer Factor / Q000627:therapeutic use*; D014923:Wiskott-Aldrich Syndrome / Q000628:therapy
D008263:Macrophage Migration-Inhibitory Factors; D014165:Transfer Factor; D013299:Streptodornase and Streptokinase